The apparent prevalence of this attitude in media and public health is eroding the credibility of those institutions, imo.
The apparent prevalence of this attitude in media and public health is eroding the credibility of those institutions, imo.
FDA… You approved the drug for use in humans and it has less side effects than acetaminophen / paracetamol… y’all.
That was bs from the FDA, but it’s ok because the folksy “y’all” is endearing to who I assume they were internally calling ”flyover hicks self-medicating with horse paste”.
All they had to say was we have not approved this medication for covid and the animal applications are not approved for use in humans, their dosages can be very dangerous.
Don't look too deep into how much life we host even when healthy; it'll squick you out.
However it's worth noting that certain multi-drug treatment regimes are looking quite promising [1][2].
Furthermore, early multi-drug treatment (before severe symptoms) using existing widely available medicines has been proven effective at reducing hospitalization and death [3][4][5][6][7]. Many front-line doctors have been using such techniques since the beginning of the pandemic, because they had to - as there were no vaccines yet and no RCTs to guide them so naturally the only option was using and combining existing medicines with established safety and efficacy profiles, the same strategy used for other difficult to treat diseases and cancers.
[1] Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial https://pubmed.ncbi.nlm.nih.gov/33983065/
[2] Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 https://pubmed.ncbi.nlm.nih.gov/33306283/
[3] Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.1...
[4] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection https://rcm.imrpress.com/EN/article/downloadArticleFile.do?a...
[5] Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents https://www.sciencedirect.com/science/article/abs/pii/S03069...
[6] Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?a...
[7] Multidrug treatment for COVID-19 https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_202...